Gregg Stetsko

Title: The Innovative Contributions of Gregg Stetsko

Introduction

Gregg Stetsko is a notable inventor based in San Diego, CA, recognized for his significant contributions to the field of pharmaceutical formulations. With a focus on enhancing the delivery of bioactive peptides and proteins, Stetsko has been awarded 2 patents that showcase his innovative approaches to drug delivery systems.

Latest Patents

Stetsko's latest patents include "Methods and compositions for enhanced transmucosal delivery of peptides and proteins." This invention provides methods and compositions aimed at improving the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, and GLP-1. The compositions consist of an absorption-enhancing mixture of a cationic polyamino acid and a compatible buffer. Additionally, he has developed "Formulations for amylin agonist peptides," which involves a pharmaceutical formulation that includes an amylin agonist, a buffer, and other stabilizers. This formulation can be delivered through various routes, including nasal and transdermal, and is designed to maintain stability under different storage conditions.

Career Highlights

Throughout his career, Gregg Stetsko has worked with prominent companies in the pharmaceutical industry, including Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His work has significantly impacted the development of innovative drug delivery systems that enhance patient care.

Collaborations

Stetsko has collaborated with notable professionals in the field, including James J L'Italien and John Ong. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Gregg Stetsko's innovative work in pharmaceutical formulations and drug delivery systems highlights his commitment to improving healthcare solutions. His patents reflect a deep understanding of biocompatible materials and their applications in medicine.